MicroRNA93 Regulates Proliferation and Differentiation of Normal and Malignant Breast Stem Cells
MicroRNAs (miRNAs) play important roles in normal cellular differentiation and oncogenesis. microRNA93 (mir-93), a member of the mir106b-25 cluster, located in intron 13 of the MCM7 gene, although frequently overexpressed in human malignancies may also function as a tumor suppressor gene. Using a series of breast cancer cell lines representing different stages of differentiation and mouse xenograft models, we demonstrate that mir-93 modulates the fate of breast cancer stem cells (BCSCs) by regulating their proliferation and differentiation states. In “claudinlow” SUM159 cells, expression of mir-93 induces Mesenchymal-Epithelial Transition (MET) associated with downregulation of TGFβ signaling and downregulates multiple stem cell regulatory genes, including JAK1, STAT3, AKT3, SOX4, EZH1, and HMGA2, resulting in cancer stem cell (CSC) depletion. Enforced expression of mir-93 completely blocks tumor development in mammary fat pads and development of metastases following intracardiac injection in mouse xenografts. The effect of mir-93 on the CSC population is dependent on the cellular differentiation state, with mir-93 expression increasing the CSC population in MCF7 cells that display a more differentiated “luminal” phenotype. mir-93 also regulates the proliferation and differentiation of normal breast stem cells isolated from reduction mammoplasties. These studies demonstrate that miRNAs can regulate the states and fates of normal and malignant mammary stem cells, findings which have important biological and clinical implications.
Vyšlo v časopise:
MicroRNA93 Regulates Proliferation and Differentiation of Normal and Malignant Breast Stem Cells. PLoS Genet 8(6): e32767. doi:10.1371/journal.pgen.1002751
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1002751
Souhrn
MicroRNAs (miRNAs) play important roles in normal cellular differentiation and oncogenesis. microRNA93 (mir-93), a member of the mir106b-25 cluster, located in intron 13 of the MCM7 gene, although frequently overexpressed in human malignancies may also function as a tumor suppressor gene. Using a series of breast cancer cell lines representing different stages of differentiation and mouse xenograft models, we demonstrate that mir-93 modulates the fate of breast cancer stem cells (BCSCs) by regulating their proliferation and differentiation states. In “claudinlow” SUM159 cells, expression of mir-93 induces Mesenchymal-Epithelial Transition (MET) associated with downregulation of TGFβ signaling and downregulates multiple stem cell regulatory genes, including JAK1, STAT3, AKT3, SOX4, EZH1, and HMGA2, resulting in cancer stem cell (CSC) depletion. Enforced expression of mir-93 completely blocks tumor development in mammary fat pads and development of metastases following intracardiac injection in mouse xenografts. The effect of mir-93 on the CSC population is dependent on the cellular differentiation state, with mir-93 expression increasing the CSC population in MCF7 cells that display a more differentiated “luminal” phenotype. mir-93 also regulates the proliferation and differentiation of normal breast stem cells isolated from reduction mammoplasties. These studies demonstrate that miRNAs can regulate the states and fates of normal and malignant mammary stem cells, findings which have important biological and clinical implications.
Zdroje
1. PetroccaFVecchioneACroceCM 2008 Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res 68 8191 8194
2. HayashitaYOsadaHTatematsuYYamadaHYanagisawaK 2005 A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65 9628 9632
3. MendellJT 2008 miRiad roles for the miR-17-92 cluster in development and disease. Cell 133 217 222
4. BandresEAgirreXRamirezNZarateRGarcia-FoncillasJ 2007 MicroRNAs as cancer players: potential clinical and biological effects. DNA Cell Biol 26 273 282
5. HernandoE 2007 microRNAs and cancer: role in tumorigenesis, patient classification and therapy. Clin Transl Oncol 9 155 160
6. NegriniMFerracinMSabbioniSCroceCM 2007 MicroRNAs in human cancer: from research to therapy. J Cell Sci 120 1833 1840
7. WiemerEA 2007 The role of microRNAs in cancer: no small matter. Eur J Cancer 43 1529 1544
8. WijnhovenBPMichaelMZWatsonDI 2007 MicroRNAs and cancer. Br J Surg 94 23 30
9. YuFYaoHZhuPZhangXPanQ 2007 let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131 1109 1123
10. ShimonoYZabalaMChoRWLoboNDalerbaP 2009 Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138 592 603
11. Esquela-KerscherATrangPWigginsJFPatrawalaLChengA 2008 The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 7 759 764
12. PolisenoLSalmenaLRiccardiLFornariASongMS 2010 Identification of the miR-106b∼25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 3 ra29
13. XuYFangFZhangJJossonSSt ClairWH 2010 miR-17* suppresses tumorigenicity of prostate cancer by inhibiting mitochondrial antioxidant enzymes. PLoS ONE 5 e14356 doi:10.1371/journal.pone.0014356
14. Al-HajjMWichaMSBenito-HernandezAMorrisonSJClarkeMF 2003 Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100 3983 3988
15. LiCHeidtDGDalerbaPBurantCFZhangL 2007 Identification of pancreatic cancer stem cells. Cancer Res 67 3 1030 1037
16. SinghSKClarkeIDTerasakiMBonnVEHawkinsC 2003 Identification of a cancer stem cell in human brain tumors. Cancer research 63 18 5821 5828
17. LiXLewisMTHuangJGutierrezCOsborneCK 2008 Therapeutic resistance and tumor-initiation: Molecular pathways involved in breast cancer stem cell self-renewal. J Natl Cancer Inst in press
18. SilberJLimDAPetritschCPerssonAIMaunakeaAK 2008 miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6 14
19. YuFYaoHZhuPZhangXPanQGongCHuangYHuXSuFLiebermanJSongE 2007 let-7 regulates self-renewal and tumorigenicity of breast cancer cells. Cell 131 1109 1123
20. Charafe-JauffretEGinestierCIovinoFWicinskiJCerveraN 2009 Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 69 1302 1313
21. IbarraIErlichYMuthuswamySKSachidanandamRHannonGJ 2007 A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells. Genes Dev 21 3238 3243
22. GinestierCHurMHCharafe-JauffretEMonvilleFDutcherJ 2007 ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1 555 567
23. LiuSWichaMS 2010 Targeting breast cancer stem cells. J Clin Oncol 28 4006 4012
24. PratAParkerJSKarginovaOFanCLivasyC 2010 Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12 R68
25. FillmoreCMKuperwasserC 2008 Human breast cancer cell lines contain stem-like cells with the capacity to self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 10 R25
26. AkhurstRJBalmainA 1999 Genetic events and the role of TGF beta in epithelial tumour progression. J Pathol 187 82 90
27. BarrackER 1997 TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity. Prostate 31 61 70
28. LimEVaillantFWuDForrestNCPalB 2009 Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15 907 913
29. WichaMSLiuSDontuG 2006 Cancer Stem Cells: An Old Idea - A Paradigm Shift. Cancer Research 66 1883 1890
30. LiZYangCSNakashimaKRanaTM 2011 Small RNA-mediated regulation of iPS cell generation. EMBO J 30 823 834
31. ManiSAGuoWLiaoMJEatonENAyyananA 2008 The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133 704 715
32. NeveRMChinKFridlyandJYehJBaehnerFL 2006 A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10 515 527
33. DontuGJacksonKWMcNicholasEKawamuraMJAbdallahWM 2004 Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast cancer research : BCR 6 6
34. LiuSDontuGMantleIDPatelSAhnNS 2006 Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66 12 6063 6071
35. IrizarryRAHobbsBCollinFBeazer-BarclayYDAntonellisKJ 2003 Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (Oxford, England) 4 249 264
36. MizutaniKSudSMcGregorNAMartinovskiGRiceBT 2009 The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment. Neoplasia 11 1235 1242
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2012 Číslo 6
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
Najčítanejšie v tomto čísle
- Rumors of Its Disassembly Have Been Greatly Exaggerated: The Secret Life of the Synaptonemal Complex at the Centromeres
- The NSL Complex Regulates Housekeeping Genes in
- Tipping the Balance in the Powerhouse of the Cell to “Protect” Colorectal Cancer
- Interplay between Synaptonemal Complex, Homologous Recombination, and Centromeres during Mammalian Meiosis